These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30765944)

  • 1. Prognostic Implications of Minimal/Covert Hepatic Encephalopathy: Large-scale Validation Cohort Studies.
    Flud CR; Duarte-Rojo A
    J Clin Exp Hepatol; 2019; 9(1):112-116. PubMed ID: 30765944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
    Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
    Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis.
    Gairing SJ; Danneberg S; Kaps L; Nagel M; Schleicher EM; Quack C; Engel S; Bittner S; Galle PR; Schattenberg JM; Wörns MA; Luessi F; Marquardt JU; Labenz C
    JHEP Rep; 2023 Apr; 5(4):100671. PubMed ID: 36866390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
    Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
    Am J Gastroenterol; 2019 May; 114(5):764-770. PubMed ID: 30848730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival.
    Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C
    J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.
    Liu A; Perumpail RB; Kumari R; Younossi ZM; Wong RJ; Ahmed A
    World J Hepatol; 2015 Dec; 7(29):2871-9. PubMed ID: 26692331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis: A retrospective cohort study.
    Miwa T; Hanai T; Hirata S; Nishimura K; Sahashi Y; Unome S; Imai K; Shirakami Y; Suetsugu A; Takai K; Shimizu M
    Clin Nutr ESPEN; 2024 Oct; 63():267-273. PubMed ID: 38972037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy.
    Yoshimura E; Ichikawa T; Miyaaki H; Taura N; Miuma S; Shibata H; Honda T; Takeshima F; Nakao K
    Biomed Rep; 2016 Aug; 5(2):193-198. PubMed ID: 27446540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients.
    Wang AJ; Peng AP; Li BM; Gan N; Pei L; Zheng XL; Hong JB; Xiao HY; Zhong JW; Zhu X
    World J Gastroenterol; 2017 Sep; 23(34):6321-6329. PubMed ID: 28974899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
    Labenz C; Baron JS; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis.
    Wang J; Deng MJ; Shi PM; Peng Y; Wang XH; Tan W; Wang PQ; Chen YX; Yuan ZL; Ning BF; Xie WF; Yin C
    J Dig Dis; 2023 Dec; 24(12):681-690. PubMed ID: 38108656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence and Its Application to Minimal Hepatic Encephalopathy Diagnosis.
    Gazda J; Drotar P; Drazilova S; Gazda J; Gazda M; Janicko M; Jarcuska P
    J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis.
    Miwa T; Hanai T; Nishimura K; Maeda T; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Shimizu M
    JPEN J Parenter Enteral Nutr; 2022 May; 46(4):858-866. PubMed ID: 34287991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy.
    Lauridsen MM; Jepsen P; Wernberg CW; Schaffalitzky de Muckadell OB; Bajaj JS; Vilstrup H
    Hepatol Commun; 2020 Sep; 4(9):1353-1361. PubMed ID: 32923838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
    Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
    Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Encephalopathy: Diagnosis and Management.
    Ridola L; Faccioli J; Nardelli S; Gioia S; Riggio O
    J Transl Int Med; 2020 Dec; 8(4):210-219. PubMed ID: 33511048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis.
    Labenz C; Nagel M; Toenges G; Kuchen R; Schattenberg JM; Hilscher M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Eur J Intern Med; 2020 Dec; 82():83-89. PubMed ID: 32873457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy.
    NeSmith M; Ahn J; Flamm SL
    Gastroenterol Hepatol (N Y); 2016 Feb; 12(2):91-100. PubMed ID: 27182210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy.
    Labenz C; Beul L; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Eur J Intern Med; 2019 Feb; 60():96-100. PubMed ID: 30131209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.